Psychedelics and Parkinson’s may trigger hallucinations through the same system, revealing how fragile the balance is between externally and internally generated perception.

Cybin is a breakthrough Phase 3 clinical-stage neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options to address the ...

Research and development (R&D) expenses were $40.2 million for the third quarter of 2025, compared to $45.4 million for the comparable period in 2024. The decrease was primarily related to the ...